The heritability of prostate cancer in the Nordic twin study of cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2303-2310

  Hjelmborg, Jacob B ^a   Scheike, Thomas ^b   Holst, Klaus ^b   Skytthe, Axel ^a   Penney, Kathryn L ^d,e   Graff, Rebecca E ^d   Pukkala, Eero ^f,i   Christensen, Kaare ^a   Adami, Hans Olov ^d,j   Holm, Niels V ^a,c   Nuttall, Elizabeth ^d   Hansen, Steinbjorn ^c   Hartman, Mikael ^j,k,l   Czene, Kamila ^j   Harris, Jennifer R ^l   Kaprio, Jaakko ^g,h   Mucci, Lorelei A ^d,e,m  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f FINNISH CANCER REGISTRY   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^j KAROLINSKA INSTITUTE   (Sweden)

^k NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^l NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^m UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER RISK; DEATH; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; HEREDITY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE CANCER; SCREENING; TWINS; AGE; DIZYGOTIC TWINS; GENETICS; INCIDENCE; MIDDLE AGED; MONOZYGOTIC TWINS; PROSTATIC NEOPLASMS; REGISTER; RISK ASSESSMENT; SCANDINAVIA; STATISTICAL BIAS; STATISTICAL MODEL; TIME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; SCANDINAVIAN AND NORDIC COUNTRIES; TIME FACTORS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84920177145     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0568     Document Type: Article

References (35)

1. Adami HO, Hunter DJ, Trichopoulos D. Textbook for cancer epidemiology. 2nd ed. New York: Oxford University Press; 2008.
2. Wilson KM, Giovannucci EL, Mucci LA. Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 2012;14:365-74.
3. HemminkiK. Familial risk and familial survival in prostate cancer. World J Urol 2012;30:143-8.
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
5. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385-91, 91e1-2.
6. Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics 2005;61:55-63.
7. Kaprio J, Koskenvuo M. Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort. Twin Res 2002;5:358-65.
8. Nilsen TS, Brandt I, Magnus P, Harris JR. The Norwegian Twin Registry. Twin Res Hum Genet 2012;15:775-80.
9. Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 2002;252: 184-205.
10. Pedersen NL, Lichtenstein P, Svedberg P. The Swedish Twin Registry in the third millennium. Twin Res 2002;5:427-32.
11. Neale MC, Cardon LR. Methodology for genetic studies of twins and families. Dordrecht: Kluwer Academic Publishers; 1992.
12. Sham P. Statistics in human genetics. Chichester: John Wiley & Sons Ltd.; 1998.
13. Allignol A, Schumacher M, Beyersmann J. Empirical Transition Matrix of Multi-State Models: the etm Package. J Stat Softw 2011;38.
14. Scheike TH, Holst KK, Hjelmborg JB. Estimating heritability for cause specific mortality based on twin studies. Lifetime Data Anal 2014;20: 201-33.
15. Scheike TH, Holst KK, Hjelmborg JB. Estimating twin concordance for bivariate competing risks twin data. Stat Med 2014;33: 1193-204.
16. Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10:733-41.
17. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-8.
18. Van der Laan MJ, Robins JM. Unified methods for censored longitudinal data and causality. Springer Series in Statistics. New York: Springer; 2003.
19. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2010;46:3040-52.
20. MeyerMS,Mucci LA, Andersson SO, Andren O, Johansson JE, Tretli S, et al. Homogeneous prostate cancer mortality in the Nordic countries over four decades. Eur Urol 2010;58:427-32.
21. Page WF, Braun MM, Partin AW, Caporaso N, Walsh P. Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997;33:240-5.
22. Cote ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 2012;48:1957-68.
23. Scheurer ME, Etzel CJ, Liu M, Barnholtz-Sloan J, Wiklund F, Tavelin B, et al. Familial aggregation of glioma: a pooled analysis.AmJ Epidemiol 2010;172:1099-107.
24. Adami HO. The prostate cancer pseudo-epidemic. Acta Oncol 2010; 49:298-304.
25. Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881-7.
26. Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000;26:411-4.
27. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012;44:312-8.
28. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011;43:1210-4.
29. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multistage genome-wide association study. Nat Genet 2011;43:785-91.
30. Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2012;131:217-34.
31. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
32. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012;90:7-24.
33. Borno ST, Fischer A, Kerick M, Falth M, Laible M, Brase JC, et al. Genome-wide DNA methylation events in TMPRSS2-ERG fusionnegative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discov 2012;2:1024-35.
34. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012;109:1193-8.
35. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. The predictive capacity of personal genome sequencing. Sci Transl Med 2012;4:133ra58.